These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A pathological study of the association between Lewy body disease and Alzheimer's disease. Gibb WR; Mann DM; Mountjoy CQ; Lees AJ Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375 [No Abstract] [Full Text] [Related]
3. Overview of morphological changes in Parkinson's disease. Jellinger K Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687 [No Abstract] [Full Text] [Related]
4. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data. Liberini P Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969 [No Abstract] [Full Text] [Related]
5. The ageing brain and dementia--a review. Davison AN Br J Clin Pract Suppl; 1985 Jun; 39():3-6. PubMed ID: 2864054 [No Abstract] [Full Text] [Related]
6. An update on the neurochemistry of Alzheimer disease. Davies P Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134 [No Abstract] [Full Text] [Related]
7. [Pathophysiology of senile dementia]. Karobath M Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521 [TBL] [Abstract][Full Text] [Related]
8. Is dementia primarily a subcortical disease? Appraisal of recent biochemical observations. Sorbi S; Amaducci L Riv Patol Nerv Ment; 1979; 100(4):220-6. PubMed ID: 95510 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. Emre M; Heckers S; Mash DC; Geula C; Mesulam MM J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109 [TBL] [Abstract][Full Text] [Related]
10. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. Arendt T; Brückner MK; Bigl V; Marcova L J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318 [TBL] [Abstract][Full Text] [Related]
11. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells. Mann DM; Yates PO J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):936. PubMed ID: 7143014 [No Abstract] [Full Text] [Related]
12. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374 [No Abstract] [Full Text] [Related]
14. Qualitative and quantitative changes in normal aging and Alzheimer's disease. Nakamura S; Nakamura S Neurobiol Aging; 1987; 8(6):578-9. PubMed ID: 2893306 [TBL] [Abstract][Full Text] [Related]
15. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. Whitehouse PJ Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448 [No Abstract] [Full Text] [Related]
16. The cholinergic system and the excitatory amino acids in Alzheimer's disease. Bowen D Acta Neurol Scand Suppl; 1990; 129():15-6. PubMed ID: 2220318 [No Abstract] [Full Text] [Related]
17. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]